Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) shares are trading lower by 11.9% to $0.19 Wednesday morning after the company announced a 1-for-20 reverse stock split.
Sonoma Pharmaceuticals公司（纳斯达克代码：SNOA）的股票在周三上午以11.9%的跌幅交易至0.19美元，因公司宣布进行1股对20股的股票逆向拆分。
The stock will trade on a split-adjusted basis starting August 30, 2024. This move aims to meet Nasdaq's $1.00 minimum bid price requirement. As a result, every 20 shares of Sonoma's common stock will be consolidated into one share, reducing the total outstanding shares from 20 million to 1 million.
从2024年8月30日开始，该股票将以拆分调整后的价位进行交易。此举旨在满足纳斯达克的1.00美元最低买盘价格要求。因此，Sonoma的每20股普通股将合并为1股，将总发行股份从2000万股减少至100万股。
No fractional shares will be issued; instead, shareholders will receive cash for any fractions. The authorized shares will also increase from 24 million to 50 million.
不会发行碎股；相反，股东将获得碎股的现金补偿。授权股份也将从2400万股增加至5000万股。
Read Also: Will Nvidia Continue To Deliver? Investors Sweat Over Hyped-up Expectations And Potential Blackwell Delay Ahead Of Q2 Report
读下文：英伟达是否将会继续交付？投资者为夸大预期和潜在的Blackwell延迟在Q2报告之前感到不安。
Should I Sell My SNOA Stock?
我应该卖出我的SNOA股票吗？
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
卖出或持有股票很大程度上取决于投资者的策略和风险承受能力。短期交易者可能会出售表现优异的股票以锁定资本收益，而长期投资者可能会在期待股价进一步增长的动荡中保持持有。
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
同样，愿意将损失最小化的交易者可能会出售下跌一定百分比的股票，而长期投资者则可能会将其视为以折扣价买入更多股票的机会。
Shares of Sonoma Pharmaceuticals have lost 75.9% year to date. This compares to the average annual return of -66.61%, meaning the stock has underperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.
Sonoma Pharmaceuticals的股票今年累计下跌75.9%，而平均年回报率为-66.61%，这意味着该股票表现低于其历史平均水平。投资者可以将一支股票的走势与其历史表现进行比较，以判断此次波动是正常的还是潜在的交易机会。
For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.
欲获取分析工具、图表数据和独家股票新闻，请登录Benzinga PRO。现在免费试用。
SNOA has a 52-week high of $1.02 and a 52-week low of $0.12.
SNOA的52周最高价为$1.02，52周最低价为$0.12。